Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hanlon

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|September 25, 2023
<i>In vivo</i> selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cordKillian S Hanlon, Ming Cheng, Demitri De La Cruz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2023
Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1FCole W Peters, Killian S Hanlon, Maryna V Ivanchenko, et al.
Frontiers in Molecular Biosciences|December 7, 2020
Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor ProgressionThomas S van Solinge, Erik R Abels, Lieke L van de Haar, et al.
Pharmaceutics|February 25, 2023
Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial DysfunctionNaomi Chadderton, Arpad Palfi, Daniel M Maloney, et al.
Human Gene Therapy|June 15, 2021
The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal AdministrationAdam Beharry, Yi Gong, James C Kim, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in miceMiguel C Santoscoy, Paula Espinoza, Killian S Hanlon, et al.
Frontiers in Microbiology|August 23, 2014
Temperature and injection water source influence microbial community structure in four Alaskan North Slope hydrocarbon reservoirsYvette M Piceno, Francine C Reid, Lauren M Tom, et al.
Molecular Therapy. Methods & Clinical Development|December 3, 2019
Selection of an Efficient AAV Vector for Robust CNS Transgene ExpressionKillian S Hanlon, Jonah C Meltzer, Tetyana Buzhdygan, et al.
Human Gene Therapy|June 28, 2023
An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain VasculatureServio H Ramirez, Jonathan F Hale, Siobhan McCarthy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 7, 2024
In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cordKillian S Hanlon, Ming Cheng, Roberto Montoro Ferrer, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|September 25, 2023
<i>In vivo</i> selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cordKillian S Hanlon, Ming Cheng, Demitri De La Cruz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2023
Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1FCole W Peters, Killian S Hanlon, Maryna V Ivanchenko, et al.
Frontiers in Molecular Biosciences|December 7, 2020
Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor ProgressionThomas S van Solinge, Erik R Abels, Lieke L van de Haar, et al.
Pharmaceutics|February 25, 2023
Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial DysfunctionNaomi Chadderton, Arpad Palfi, Daniel M Maloney, et al.
Human Gene Therapy|June 15, 2021
The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal AdministrationAdam Beharry, Yi Gong, James C Kim, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in miceMiguel C Santoscoy, Paula Espinoza, Killian S Hanlon, et al.
Frontiers in Microbiology|August 23, 2014
Temperature and injection water source influence microbial community structure in four Alaskan North Slope hydrocarbon reservoirsYvette M Piceno, Francine C Reid, Lauren M Tom, et al.
Molecular Therapy. Methods & Clinical Development|December 3, 2019
Selection of an Efficient AAV Vector for Robust CNS Transgene ExpressionKillian S Hanlon, Jonah C Meltzer, Tetyana Buzhdygan, et al.
Human Gene Therapy|June 28, 2023
An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain VasculatureServio H Ramirez, Jonathan F Hale, Siobhan McCarthy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 7, 2024
In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cordKillian S Hanlon, Ming Cheng, Roberto Montoro Ferrer, et al.
Pageof 7